Patents Assigned to Epidestiny, Inc.
  • COMPOSITIONS CONTAINING DECITABINE, 5AZACYTIDINE AND TETRAHYDROURIDINE AND USES THEREOF
    Publication number: 20240165142
    Abstract: Compositions comprising decitabine and tetrahydrouridine or 5-azacytidine and tetrahydrouridine for the treatment of cancer are disclosed. The compositions in the form of a pill is administered to a human subject sequentially or alternately guided by the measurement of predictive biomarkers.
    Type: Application
    Filed: September 1, 2023
    Publication date: May 23, 2024
    Applicant: EpiDestiny, Inc.
    Inventors: Yogen SAUNTHARARAJAH, Joseph DESIMONE, Henry LAU, Santhosh VADIVELU
  • Compositions containing decitabine, 5azacytidine and tetrahydrouridine and uses thereof
    Patent number: 11779591
    Abstract: Compositions comprising decitabine and tetrahydrouridine or 5-azacytidine and tetrahydrouridine for the treatment of cancer are disclosed. The compositions in the form of a pill is administered to a human subject sequentially or alternately guided by the measurement of predictive biomarkers.
    Type: Grant
    Filed: January 27, 2022
    Date of Patent: October 10, 2023
    Assignee: EPIDESTINY, INC.
    Inventors: Yogen Saunthararajah, Joseph Desimone, Henry Lau, Santhosh Vadivelu
  • Compositions containing decitabine, 5Azacytidine and tetrahydrouridine and uses thereof
    Patent number: 11376270
    Abstract: Compositions comprising decitabine and tetrahydrouridine or 5-azacytidine and tetrahydrouridine for the treatment of cancer are disclosed. The compositions in the form of a pill is administered to a human subject sequentially or alternately guided by the measurement of predictive biomarkers.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: July 5, 2022
    Assignee: EPIDESTINY, INC.
    Inventors: Yogen Saunthararajah, Joseph Desimone, Henry Lau, Santhosh Vadivelu
  • COMPOSITIONS CONTAINING DECITABINE, 5AZACYTIDINE AND TETRAHYDROURIDINE AND USES THEREOF
    Publication number: 20220152075
    Abstract: Compositions comprising decitabine and tetrahydrouridine or 5-azacytidine and tetrahydrouridine for the treatment of cancer are disclosed. The compositions in the form of a pill is administered to a human subject sequentially or alternately guided by the measurement of predictive biomarkers.
    Type: Application
    Filed: January 27, 2022
    Publication date: May 19, 2022
    Applicant: Epidestiny, Inc.
    Inventors: Yogen SAUNTHARARAJAH, Joseph DESIMONE, Henry LAU, Santhosh VADIVELU
  • Compositions Containing Decitabine, 5Azacytidine and Tetrahydrouridine and Uses Thereof
    Publication number: 20200246368
    Abstract: Compositions comprising decitabine and tetrahydrouridine or 5-azacytidine and tetrahydrouridine for the treatment of cancer are disclosed. The compositions in the form of a pill is administered to a human subject sequentially or alternately guided by the measurement of predictive biomarkers.
    Type: Application
    Filed: December 5, 2016
    Publication date: August 6, 2020
    Applicant: Epidestiny, Inc.
    Inventors: Yogen Saunthararajah, Joseph Desimone, Henry Lau, Santhosh Vadivelu